Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NIH 3OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 42Uterine Cervical Neoplasms 41Breast Neoplasms 10Vaginal Neoplasms 6Neoplasms 6Endometrial Neoplasms 6Liver Neoplasms 5Uterine Neoplasms 4Sarcoma 4Lung Neoplasms 4Esophageal Neoplasms 4Vulvar Neoplasms 3Retinoblastoma 3Radiation Injuries 3Ovarian Neoplasms 3Hyperthermia 3Carcinoma, Hepatocellular 3Adenocarcinoma 3Rhabdomyosarcoma 2Rectal Neoplasms 2Melanoma 2Head and Neck Neoplasms 2Gynecologic Cancer 2Desmoplastic Small Round Cell Tumor 2Deglutition Disorders 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Ductal, Breast 2Breast Carcinoma In Situ 2Uveal Melanoma 1

Interventions

Temozolomide 264Radiotherapy 119Bevacizumab 105Magnetic Resonance Spectroscopy 59Radiation 47pembrolizumab 30Irinotecan 28Surgical Procedures, Operative 23Lomustine 21Specimen Handling 19Nivolumab 19Radiosurgery 18Carmustine 18Aminolevulinic Acid 16Erlotinib Hydrochloride 15Drug Therapy 15Blood Specimen Collection 14Radiotherapy, Intensity-Modulated 13O(6)-benzylguanine 13Chemotherapy, Adjuvant 13Carboplatin 13Filgrastim 11Cyclophosphamide 11sargramostim 10poly ICLC 10atezolizumab 10Thalidomide 10Etoposide 10Ipilimumab 9Everolimus 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Glioblastoma × Brachytherapy × Clear all
NCT00376103 2009-09-18

Radiation Boost for Newly Diagnosed Glioblastoma Multiforme

Methodist Healthcare - Memphis

Phase 1/2 Terminated
3 enrolled
CNS

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡